Abstract
Background
A promising approach to the treatment of chronic ischaemic heart disease (IHD) and heart failure is the use of stem cells.
The last decade has seen a plethora of randomised controlled trials (RCTs) developed worldwide which have generated conflicting results.
Objectives
The critical evaluation of clinical evidence on the safety and efficacy of autologous adult bone marrow-derived stem cells (BMSC) as a treatment for chronic ischaemic heart disease (IHD) and heart failure. Ver más…